Literature DB >> 31309436

In favor of total neoadjuvant therapy (TNT) for locally advanced rectal carcinoma.

F Arias1, G Asín2, S Flamarique2, I Hernández3, J Suarez4.   

Abstract

Entities:  

Year:  2019        PMID： 31309436     DOI： 10.1007/s12094-019-02177-w

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN： 1699-048X            Impact factor:   3.405


× No keyword cloud information.
  13 in total

Review 1.  Future directions in neoadjuvant therapy of rectal cancer: maximizing pathological complete response rates.

Authors:  Mohammed Mohiuddin; Majid M Mohiuddin; John Marks; Gerald Marks
Journal:  Cancer Treat Rev       Date:  2009-06-17       Impact factor: 12.111

2.  Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial.

Authors:  Julio Garcia-Aguilar; Oliver S Chow; David D Smith; Jorge E Marcet; Peter A Cataldo; Madhulika G Varma; Anjali S Kumar; Samuel Oommen; Theodore Coutsoftides; Steven R Hunt; Michael J Stamos; Charles A Ternent; Daniel O Herzig; Alessandro Fichera; Blase N Polite; David W Dietz; Sujata Patil; Karin Avila
Journal:  Lancet Oncol       Date:  2015-07-14       Impact factor: 41.316

3.  Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised controlled trials.

Authors:  Hans-Joachim Schmoll; Chris Twelves; Weijing Sun; Michael J O'Connell; Thomas Cartwright; Edward McKenna; Muhammad Saif; Steve Lee; Greg Yothers; Daniel Haller
Journal:  Lancet Oncol       Date:  2014-11-12       Impact factor: 41.316

4.  Neoadjuvant chemotherapy first, followed by chemoradiation and then surgery, in the management of locally advanced rectal cancer.

Authors:  Andrea Cercek; Karyn A Goodman; Carla Hajj; Emily Weisberger; Neil H Segal; Diane L Reidy-Lagunes; Zsofia K Stadler; Abraham J Wu; Martin R Weiser; Philip B Paty; Jose G Guillem; Garrett M Nash; Larissa K Temple; Julio Garcia-Aguilar; Leonard B Saltz
Journal:  J Natl Compr Canc Netw       Date:  2014-04       Impact factor: 11.908

5.  Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer.

Authors:  Andrea Cercek; Campbell S D Roxburgh; Paul Strombom; J Joshua Smith; Larissa K F Temple; Garrett M Nash; Jose G Guillem; Philip B Paty; Rona Yaeger; Zsofia K Stadler; Kenneth Seier; Mithat Gonen; Neil H Segal; Diane L Reidy; Anna Varghese; Jinru Shia; Efsevia Vakiani; Abraham J Wu; Christopher H Crane; Marc J Gollub; Julio Garcia-Aguilar; Leonard B Saltz; Martin R Weiser
Journal:  JAMA Oncol       Date:  2018-06-14       Impact factor: 31.777

6.  Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer.

Authors:  Ian Chau; Gina Brown; David Cunningham; Diana Tait; Andrew Wotherspoon; Andrew R Norman; Niall Tebbutt; Mark Hill; Paul J Ross; Alison Massey; Jacqueline Oates
Journal:  J Clin Oncol       Date:  2006-02-01       Impact factor: 44.544

7.  Chemoradiation, surgery and adjuvant chemotherapy versus induction chemotherapy followed by chemoradiation and surgery: long-term results of the Spanish GCR-3 phase II randomized trial†.

Authors:  C Fernandez-Martos; X Garcia-Albeniz; C Pericay; J Maurel; J Aparicio; C Montagut; M J Safont; A Salud; R Vera; B Massuti; P Escudero; V Alonso; C Bosch; M Martin; B D Minsky
Journal:  Ann Oncol       Date:  2015-05-08       Impact factor: 32.976

Review 8.  Organ preservation in rectal cancer - Challenges and future strategies.

Authors:  C Gani; P Bonomo; K Zwirner; C Schroeder; A Menegakis; C Rödel; D Zips
Journal:  Clin Transl Radiat Oncol       Date:  2017-03-23

Review 9.  Watch-and-Wait as a Therapeutic Strategy in Rectal Cancer.

Authors:  Laurence Bernier; Svetlana Balyasnikova; Diana Tait; Gina Brown
Journal:  Curr Colorectal Cancer Rep       Date:  2018-03-07

10.  Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management.

Authors:  J Joshua Smith; Oliver S Chow; Marc J Gollub; Garrett M Nash; Larissa K Temple; Martin R Weiser; José G Guillem; Philip B Paty; Karin Avila; Julio Garcia-Aguilar
Journal:  BMC Cancer       Date:  2015-10-23       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.